HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FTC Weight-Loss Ad Guidelines Could Gain Support At November Workshop

This article was originally published in The Tan Sheet

Executive Summary

The Federal Trade Commission could look to develop a formal set of guidelines specifically for the marketing of dietary supplements claiming weight-loss benefits

You may also be interested in...

DSHEA Legislative Reform Effort Likely In 108th Congress Behind Sen. Durbin

Legislation to amend the Dietary Supplement Health & Education Act is a long-term goal of Sen. Richard Durbin (D-Ill.), according to his staff

Supplements Claim Weight Loss Without Diet, Exercise In 55% Of FTC Sample

More than half of the dietary supplement ads reviewed in a recent study by Federal Trade Commission staff claimed to produce weight loss without a reduction in caloric intake or increased physical activity, according to an FTC report released Sept. 17

CRN Structure/Function Claim Substantiation Document Under Development

The Council for Responsible Nutrition is in the process of drafting substantiation criteria for dietary supplement structure/function claims

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts